Free Trial

Douglas Elliman (DOUG) Financials

Douglas Elliman logo
$1.54 -0.02 (-0.96%)
Closing price 10/9/2026 03:59 PM Eastern
Extended Trading
$1.54 0.00 (0.00%)
As of 10/9/2026 05:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Douglas Elliman

Annual Income Statements for Douglas Elliman

This table shows Douglas Elliman's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
8.46 -46 99 -5.62 -43 -76 15
Consolidated Net Income / (Loss)
8.46 -46 99 -6.40 -43 -77 14
Net Income / (Loss) Continuing Operations
8.46 -46 99 -6.40 -43 -77 14
Total Pre-Tax Income
8.81 -46 101 0.10 -58 -76 18
Total Operating Income
-3.48 -49 102 -4.54 -64 -69 45
Total Gross Profit
179 162 281 221 179 181 190
Total Revenue
784 774 1,353 1,153 956 996 1,033
Operating Revenue
784 774 1,353 1,153 956 996 1,033
Total Cost of Revenue
606 612 1,073 933 777 814 843
Operating Cost of Revenue
606 612 1,073 933 777 814 843
Total Operating Expenses
182 212 179 225 243 250 145
Selling, General & Admin Expense
97 76 93 131 125 118 111
Marketing Expense
77 64 77 86 84 83 81
Depreciation Expense
8.64 8.54 8.56 8.01 8.03 7.74 8.38
Other Operating Expenses / (Income)
- - - 0.00 24 23 -59
Impairment Charge
0.00 58 - - 0.00 0.00 2.28
Restructuring Charge
0.00 3.38 0.00 0.00 2.38 1.04 1.64
Other Special Charges / (Income)
0.00 1.17 - - 0.00 18 0.00
Total Other Income / (Expense), net
12 2.96 -1.31 4.65 6.28 -7.06 -28
Interest Expense
- - - 0.15 0.03 2.94 5.54
Interest & Investment Income
9.14 0.81 0.33 4.79 6.31 11 6.41
Other Income / (Expense), net
3.16 2.15 -1.65 0.00 0.00 -15 -28
Income Tax Expense
0.35 0.04 2.13 6.50 -15 1.12 3.56
Net Income / (Loss) Attributable to Noncontrolling Interest
0.00 0.00 -0.19 -0.78 -0.61 -0.69 -0.91
Basic Earnings per Share
$0.11 ($0.60) $1.21 ($0.08) ($0.52) ($0.91) $0.17
Weighted Average Basic Shares Outstanding
- - 81.26M 84.42M 91.54M 88.74M 88.22M
Diluted Earnings per Share
$0.11 ($0.60) $1.21 ($0.08) ($0.52) ($0.91) $0.17
Weighted Average Diluted Shares Outstanding
- - 81.26M 84.42M 91.54M 88.74M 88.22M
Weighted Average Basic & Diluted Shares Outstanding
- - 81.26M 84.42M 91.54M 88.74M 88.22M

Quarterly Income Statements for Douglas Elliman

This table shows Douglas Elliman's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-15 -41 -1.66 -27 -6.00 -99 -23 -25 162 -83 -2.73
Consolidated Net Income / (Loss)
-15 -42 -1.78 -27 -6.09 -13 -23 -25 74 -33 -2.73
Net Income / (Loss) Continuing Operations
-15 -42 -1.78 -27 -6.09 -100 -23 -25 162 -83 -2.73
Total Pre-Tax Income
-22 -40 -1.61 -27 -6.34 -13 -23 -25 78 -33 -2.73
Total Operating Income
-24 -41 -3.67 -7.43 -16 -11 -5.53 -11 72 -35 -3.43
Total Gross Profit
55 27 46 42 43 0.00 49 47 101 0.00 41
Total Revenue
214 200 286 266 243 0.00 271 263 499 0.00 283
Operating Revenue
214 200 286 266 243 - 271 263 - - 283
Total Cost of Revenue
159 174 240 224 200 0.00 222 216 398 0.00 242
Operating Cost of Revenue
159 174 240 224 200 - 222 216 - - 242
Total Operating Expenses
79 68 50 50 60 98 55 57 -59 86 45
Selling, General & Admin Expense
33 27 25 29 37 55 26 32 -2.10 46 18
Marketing Expense
20 21 22 19 20 39 20 20 1.45 35 20
Depreciation Expense
2.00 1.98 1.93 1.90 1.93 3.80 2.22 2.18 0.18 4.00 1.99
Other Operating Expenses / (Income)
- - 0.00 0.00 - - 5.77 0.00 - - 5.18
Restructuring Charge
0.45 - 0.60 0.02 0.43 0.00 0.30 0.79 0.54 0.09 0.15
Other Special Charges / (Income)
- 18 - - - - 0.00 - - - 0.00
Total Other Income / (Expense), net
2.05 0.97 2.07 -20 9.92 -1.83 -17 -14 5.58 2.55 0.69
Interest Expense
- 0.01 0.01 1.46 - 3.06 1.55 1.57 -0.64 0.01 0.00
Interest & Investment Income
2.08 0.98 2.07 1.61 6.21 2.73 1.42 2.74 -0.48 2.56 0.69
Other Income / (Expense), net
- 0.00 0.00 -20 - -1.49 -17 -15 5.42 0.00 0.00
Income Tax Expense
-6.50 1.20 0.17 0.00 -0.25 0.00 0.00 0.01 3.55 0.00 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
-0.18 -0.21 -0.12 -0.27 -0.09 -0.30 0.05 -0.25 -0.41 0.00 0.00
Basic Earnings per Share
($0.18) ($0.50) ($0.02) ($0.33) ($0.06) ($0.07) ($0.27) ($0.29) $0.80 ($0.19) ($0.03)
Weighted Average Basic Shares Outstanding
91.54M 91.42M 91.83M 89.17M 88.74M 88.74M 88.71M 88.82M 88.22M 90.91M 90.89M
Diluted Earnings per Share
($0.18) ($0.50) ($0.02) ($0.33) ($0.06) ($0.07) ($0.27) ($0.29) $0.80 ($0.19) ($0.03)
Weighted Average Diluted Shares Outstanding
91.54M 91.42M 91.83M 89.17M 88.74M 88.74M 88.71M 88.82M 88.22M 90.91M 90.89M
Weighted Average Basic & Diluted Shares Outstanding
91.54M 91.42M 91.83M 89.17M 88.74M 88.74M 88.71M 88.82M 88.22M 90.91M 90.89M

Annual Cash Flow Statements for Douglas Elliman

This table details how cash moves in and out of Douglas Elliman's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-13 28 122 -57 -42 13 -20
Net Cash From Operating Activities
7.58 32 128 -15 -30 -26 -14
Net Cash From Continuing Operating Activities
7.58 32 128 -15 -30 -26 -14
Net Income / (Loss) Continuing Operations
8.46 -46 99 -6.40 -43 -77 14
Consolidated Net Income / (Loss)
8.46 -46 99 -6.40 -43 -77 14
Depreciation Expense
8.64 8.54 8.56 8.01 8.03 7.74 8.38
Non-Cash Adjustments To Reconcile Net Income
12 79 22 39 41 67 -21
Changes in Operating Assets and Liabilities, net
-21 -8.88 -1.66 -55 -36 -24 -16
Net Cash From Investing Activities
-1.51 -4.09 -8.86 -13 -5.24 -6.79 90
Net Cash From Continuing Investing Activities
-1.51 -4.09 -8.86 -13 -5.24 -6.79 90
Purchase of Property, Plant & Equipment
-8.08 -6.13 -4.11 -8.54 -6.14 -5.53 -3.35
Purchase of Investments
0.00 0.00 -0.37 -1.78 -0.22 -10 -88
Divestitures
- - - - 0.00 0.00 82
Sale and/or Maturity of Investments
8.62 0.00 0.09 0.08 1.42 8.88 99
Other Investing Activities, net
0.00 0.00 -3.98 -2.10 -0.30 0.00 0.00
Net Cash From Financing Activities
-19 -0.14 3.20 -30 -6.21 45 -96
Net Cash From Continuing Financing Activities
-19 -0.14 3.20 -30 -6.21 45 -96
Repayment of Debt
-0.16 -0.06 -0.36 -13 0.00 -2.00 -94
Payment of Dividends
-19 0.00 -31 -16 -4.22 0.00 0.00
Issuance of Debt
- - - 0.00 0.00 49 0.00
Other Financing Activities, net
-0.22 -0.08 -0.13 -1.60 -1.99 -1.30 -2.03

Quarterly Cash Flow Statements for Douglas Elliman

This table details how cash moves in and out of Douglas Elliman's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
-4.37 -29 2.84 54 -15 3.16 -0.68 6.20 -28 -20 11
Net Cash From Operating Activities
-2.64 -27 1.32 8.99 -8.98 -5.62 0.64 5.48 -14 -19 12
Net Cash From Continuing Operating Activities
-2.64 -27 1.32 8.99 -8.98 -5.62 0.64 5.48 -14 -19 12
Net Income / (Loss) Continuing Operations
-15 -42 -1.78 -27 -6.09 -6.28 -23 -25 68 -16 -2.73
Consolidated Net Income / (Loss)
-15 -42 -1.78 -27 -6.09 -6.28 -23 -25 68 -16 -2.73
Depreciation Expense
2.00 1.98 1.93 1.90 1.93 1.90 2.22 2.18 2.08 2.00 1.99
Non-Cash Adjustments To Reconcile Net Income
11 32 -8.48 35 6.14 7.24 24 25 -77 1.69 5.29
Changes in Operating Assets and Liabilities, net
-0.16 -20 9.65 -0.46 -11 -8.47 -2.59 3.07 -7.82 -11 12
Net Cash From Investing Activities
0.25 -2.16 1.53 -1.38 -4.78 8.78 -1.23 0.72 82 -0.39 -0.68
Net Cash From Continuing Investing Activities
0.25 -2.16 1.53 -1.38 -4.78 8.78 -1.23 0.72 82 -0.39 -0.68
Purchase of Property, Plant & Equipment
-0.76 -2.08 -0.89 -1.31 -1.26 -1.03 -1.22 -0.79 -0.31 -0.26 -0.68
Purchase of Investments
- -0.09 -0.10 -0.07 -9.88 -45 -43 -0.03 -0.03 -0.16 -0.02
Net Cash From Financing Activities
-1.98 0.00 -0.01 47 -1.29 0.00 -0.09 - -96 0.00 -0.03
Net Cash From Continuing Financing Activities
-1.98 0.00 -0.01 47 -1.29 0.00 -0.09 - -96 0.00 -0.03

Annual Balance Sheets for Douglas Elliman

This table presents Douglas Elliman's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
454 595 550 493 494 444
Total Current Assets
148 281 225 181 196 161
Cash & Equivalents
94 212 164 120 136 116
Restricted Cash
10 15 4.99 7.17 4.08 4.72
Accounts Receivable
24 32 22 22 20 20
Other Current Assets
19 21 27 27 27 21
Plant, Property, & Equipment, net
43 39 42 40 38 30
Total Noncurrent Assets
263 275 284 272 260 253
Long-Term Investments
1.65 11 15 15 12 13
Goodwill
32 33 32 32 32 32
Intangible Assets
68 74 74 73 72 72
Other Noncurrent Operating Assets
161 157 163 151 144 136
Total Liabilities & Shareholders' Equity
454 595 550 493 494 444
Total Liabilities
290 313 280 259 331 261
Total Current Liabilities
100 132 90 97 92 99
Accounts Payable
6.34 5.87 5.46 6.14 3.06 3.78
Current Deferred & Payable Income Tax Liabilities
0.02 1.24 - - 0.00 3.56
Current Employee Benefit Liabilities
12 25 18 13 8.30 14
Other Current Liabilities
69 87 66 78 81 78
Total Noncurrent Liabilities
191 181 190 162 239 162
Asset Retirement Reserve & Litigation Obligation
- - - 0.00 10 5.00
Other Noncurrent Operating Liabilities
178 169 176 162 197 157
Commitments & Contingencies
0.00 0.00 0.00 - - 0.00
Total Equity & Noncontrolling Interests
164 282 270 234 162 183
Total Preferred & Common Equity
164 280 269 233 162 184
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
0.00 280 269 233 162 184
Common Stock
0.00 279 274 281 286 293
Retained Earnings
0.00 0.62 -5.00 -48 -124 -109
Noncontrolling Interest
0.00 1.94 1.54 0.92 0.24 -0.67

Quarterly Balance Sheets for Douglas Elliman

This table presents Douglas Elliman's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
511 461 464 503 494 489 481 435 444
Total Current Assets
197 155 161 206 196 192 193 151 160
Cash & Equivalents
126 91 93 151 137 136 143 96 105
Restricted Cash
5.01 6.08 7.56 3.36 6.13 5.89 5.42 4.52 6.00
Accounts Receivable
27 20 28 22 21 21 18 21 22
Other Current Assets
33 37 34 29 32 29 27 30 27
Plant, Property, & Equipment, net
41 40 39 38 37 36 32 29 27
Total Noncurrent Assets
273 267 264 259 261 261 255 255 257
Long-Term Investments
15 13 13 13 13 13 13 12 12
Goodwill
32 32 32 32 32 32 32 32 32
Intangible Assets
73 73 73 72 72 72 72 71 71
Other Noncurrent Operating Assets
153 148 146 141 144 143 138 140 141
Total Liabilities & Shareholders' Equity
511 461 464 503 494 489 481 435 444
Total Liabilities
263 265 266 329 336 351 366 267 277
Total Current Liabilities
93 93 91 90 101 97 101 102 105
Accounts Payable
4.75 5.44 2.73 2.82 5.22 3.11 3.61 3.27 3.29
Current Deferred & Payable Income Tax Liabilities
- 0.16 0.34 0.34 0.08 0.08 0.01 2.41 0.21
Current Employee Benefit Liabilities
9.98 2.27 3.37 5.50 3.30 5.80 9.49 5.85 7.09
Other Current Liabilities
78 85 84 81 92 88 87 91 94
Total Noncurrent Liabilities
170 173 176 239 235 255 265 165 172
Asset Retirement Reserve & Litigation Obligation
- 10 10 10 5.00 5.00 5.00 0.00 1.94
Other Noncurrent Operating Liabilities
165 163 166 197 197 216 226 165 170
Commitments & Contingencies
0.00 0.00 0.00 0.00 - - 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
248 196 198 174 158 138 115 168 167
Total Preferred & Common Equity
247 195 197 174 158 138 115 168 167
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
247 195 197 174 158 138 115 168 167
Common Stock
279 284 288 291 288 290 292 293 295
Retained Earnings
-33 -89 -91 -118 -130 -153 -177 -125 -128
Noncontrolling Interest
1.10 0.71 0.60 0.33 -0.06 -0.01 -0.27 0.00 0.00

Annual Metrics And Ratios for Douglas Elliman

This table displays calculated financial ratios and metrics derived from Douglas Elliman's official financial filings.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 0.00 0.00 81,248,163.00 88,707,320.00 - 88,818,970.00
DEI Adjusted Shares Outstanding
0.00 0.00 0.00 81,248,163.00 88,707,320.00 - 88,818,970.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 0.00 0.00 -0.07 -0.48 - 0.17
Growth Metrics
- - - - - - -
Revenue Growth
0.00% -1.29% 74.83% -14.78% -17.14% 4.19% 3.76%
EBITDA Growth
0.00% -564.21% 382.42% -96.82% -1,726.94% -34.70% 133.36%
EBIT Growth
0.00% -14,493.19% 313.11% -104.52% -1,320.33% -29.93% 120.29%
NOPAT Growth
0.00% -932.85% 389.68% 179.58% -116.16% -6.71% 175.60%
Net Income Growth
0.00% -648.20% 312.74% -106.49% -574.57% -78.39% 118.58%
EPS Growth
0.00% -645.45% 301.67% -106.61% -550.00% -75.00% 118.68%
Operating Cash Flow Growth
0.00% 320.55% 301.15% -111.53% -106.29% 14.64% 46.55%
Free Cash Flow Firm Growth
0.00% 0.00% 207.21% 98.69% -120.23% 120.14% 98.13%
Invested Capital Growth
0.00% 0.00% -30.96% 52.72% 6.08% -63.17% 47.91%
Revenue Q/Q Growth
0.00% 0.00% 0.00% -9.91% 0.72% 3.02% 32.86%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% -92.23% -3.09% -11.31% 139.88%
EBIT Q/Q Growth
0.00% 0.00% 0.00% -112.44% -2.72% -10.07% 123.66%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 870.12% -2.72% 9.60% 220.60%
Net Income Q/Q Growth
0.00% 0.00% 0.00% -119.76% 7.78% 10.39% 121.61%
EPS Q/Q Growth
0.00% 0.00% 0.00% -122.86% 8.77% 11.65% 124.64%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% -137.23% 36.27% -32.26% -63.85%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 19.67% 1.38% 3.33%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 5.60% -8.82% -10.41% 529.09%
Profitability Metrics
- - - - - - -
Gross Margin
22.78% 20.97% 20.74% 19.13% 18.71% 15.88% 18.43%
EBITDA Margin
1.06% -4.99% 8.06% 0.30% -5.91% -7.64% 2.46%
Operating Margin
-0.44% -6.37% 7.55% -0.39% -6.75% -6.91% 4.40%
EBIT Margin
-0.04% -6.09% 7.42% -0.39% -6.75% -8.42% 1.65%
Profit (Net Income) Margin
1.08% -5.99% 7.29% -0.55% -4.52% -7.73% 1.39%
Tax Burden Percent
95.98% 100.10% 97.88% -6,152.88% 74.14% 101.47% 80.08%
Interest Burden Percent
-2,728.48% 98.29% 100.33% -2.29% 90.27% 90.55% 105.12%
Effective Tax Rate
4.02% 0.00% 2.12% 6,252.88% 0.00% 0.00% 19.92%
Return on Invested Capital (ROIC)
0.00% -83.57% 143.21% 387.91% -50.33% -76.26% 86.40%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -54.26% 144.05% 527.92% -51.55% -54.93% 103.32%
Return on Net Nonoperating Assets (RNNOA)
0.00% 26.88% -98.92% -390.23% 33.22% 37.43% -78.13%
Return on Equity (ROE)
0.00% -56.69% 44.29% -2.32% -17.11% -38.83% 8.28%
Cash Return on Invested Capital (CROIC)
0.00% -283.57% 179.84% 346.19% -56.23% 16.08% 47.75%
Operating Return on Assets (OROA)
0.00% -10.38% 19.15% -0.79% -12.36% -16.98% 3.62%
Return on Assets (ROA)
0.00% -10.21% 18.81% -1.12% -8.27% -15.60% 3.05%
Return on Common Equity (ROCE)
0.00% 0.00% 27.83% -2.30% -17.03% -38.72% 8.29%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00% 0.00% -47.48% 0.00%
Net Operating Profit after Tax (NOPAT)
-3.34 -34 100 279 -45 -48 36
NOPAT Margin
-0.43% -4.46% 7.39% 24.23% -4.72% -4.84% 3.53%
Net Nonoperating Expense Percent (NNEP)
0.00% -29.31% -0.84% -140.00% 1.22% -21.33% -16.92%
Return On Investment Capital (ROIC_SIMPLE)
- -18.25% 33.93% 103.31% -19.28% -24.69% 19.87%
Cost of Revenue to Revenue
77.22% 79.03% 79.26% 80.87% 81.29% 84.12% 81.57%
SG&A Expenses to Revenue
12.31% 9.84% 6.86% 11.40% 13.13% 11.83% 10.74%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
23.22% 27.34% 13.19% 19.53% 25.46% 22.79% 14.02%
Earnings before Interest and Taxes (EBIT)
-0.32 -47 100 -4.54 -64 -84 17
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
8.32 -39 109 3.47 -56 -76 25
Valuation Ratios
- - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 1.15 1.12 0.92 1.14
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 1.90 2.04 2.58 2.63
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.27 0.27 0.15 0.20
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 13.83
Dividend Yield
0.00% 0.00% 0.00% 5.25% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 7.23%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 1.47 1.31 0.61 1.53
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.11 0.13 0.02 0.07
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 36.85 0.00 0.00 3.03
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 4.52
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.46 0.00 0.00 2.11
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.51 0.00 2.04 3.82
Leverage & Solvency
- - - - - - -
Debt to Equity
0.00 0.16 0.05 0.00 0.00 0.20 0.00
Long-Term Debt to Equity
0.00 0.08 0.00 0.00 0.00 0.20 0.00
Financial Leverage
0.00 -0.50 -0.69 -0.74 -0.64 -0.68 -0.76
Leverage Ratio
0.00 2.78 2.36 2.07 2.07 2.49 2.71
Compound Leverage Factor
0.00 2.73 2.36 -0.05 1.87 2.25 2.85
Debt to Total Capital
0.00% 13.45% 4.31% 0.00% 0.00% 16.75% 0.00%
Short-Term Debt to Total Capital
0.00% 6.61% 4.25% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 6.84% 0.06% 0.00% 0.00% 16.75% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.66% 0.57% 0.39% 0.12% -0.37%
Common Equity to Total Capital
0.00% 0.00% 95.03% 99.43% 99.61% 83.13% 100.37%
Debt to EBITDA
0.00 -0.66 0.12 0.00 0.00 -0.43 0.00
Net Debt to EBITDA
0.00 2.10 -2.06 0.00 0.00 1.69 0.00
Long-Term Debt to EBITDA
0.00 -0.33 0.00 0.00 0.00 -0.43 0.00
Debt to NOPAT
0.00 -0.74 0.13 0.00 0.00 -0.68 0.00
Net Debt to NOPAT
0.00 2.35 -2.25 0.00 0.00 2.67 0.00
Long-Term Debt to NOPAT
0.00 -0.37 0.00 0.00 0.00 -0.68 0.00
Altman Z-Score
0.00 0.00 0.00 3.01 2.18 1.63 2.76
Noncontrolling Interest Sharing Ratio
0.00% 100.00% 37.16% 0.63% 0.49% 0.29% -0.13%
Liquidity Ratios
- - - - - - -
Current Ratio
0.00 1.49 2.12 2.50 1.86 2.13 1.63
Quick Ratio
0.00 1.19 1.84 2.07 1.46 1.79 1.37
Cash Flow Metrics
- - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -117 126 249 -50 10 20
Operating Cash Flow to CapEx
93.79% 520.16% 3,113.15% -172.71% -495.12% -469.14% -413.90%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 1,684.81 -1,801.43 3.46 3.64
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 -99.62 -1,086.25 -8.83 -2.51
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 -157.30 -1,305.64 -10.72 -3.11
Efficiency Ratios
- - - - - - -
Asset Turnover
0.00 1.70 2.58 2.01 1.83 2.02 2.20
Accounts Receivable Turnover
0.00 31.75 47.59 42.20 43.46 48.09 52.30
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 18.12 32.97 28.44 23.47 25.72 30.45
Accounts Payable Turnover
0.00 96.53 175.66 164.61 134.02 182.23 246.44
Days Sales Outstanding (DSO)
0.00 11.50 7.67 8.65 8.40 7.59 6.98
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 3.78 2.08 2.22 2.72 2.00 1.48
Cash Conversion Cycle (CCC)
0.00 7.71 5.59 6.43 5.67 5.59 5.50
Capital & Investment Metrics
- - - - - - -
Invested Capital
0.00 83 57 87 92 34 50
Invested Capital Turnover
0.00 18.75 19.39 16.01 10.65 15.76 24.51
Increase / (Decrease) in Invested Capital
0.00 83 -26 30 5.29 -58 16
Enterprise Value (EV)
0.00 0.00 0.00 128 121 21 77
Market Capitalization
0.00 0.00 0.00 310 262 149 211
Book Value per Share
$0.00 $0.00 $3.44 $3.31 $2.63 $1.82 $2.07
Tangible Book Value per Share
$0.00 $0.00 $2.13 $2.01 $1.44 $0.65 $0.90
Total Capital
0.00 189 295 270 234 195 183
Total Debt
0.00 25 13 0.00 0.00 33 0.00
Total Long-Term Debt
0.00 13 0.18 0.00 0.00 33 0.00
Net Debt
0.00 -81 -225 -183 -142 -128 -133
Capital Expenditures (CapEx)
8.08 6.13 4.11 8.54 6.14 5.53 3.35
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -44 -66 -34 -43 -46 -58
Debt-free Net Working Capital (DFNWC)
0.00 61 161 135 84 104 63
Net Working Capital (NWC)
0.00 49 148 135 84 104 63
Net Nonoperating Expense (NNE)
-12 12 1.29 286 -1.98 29 22
Net Nonoperating Obligations (NNO)
0.00 -81 -225 -183 -142 -128 -133
Total Depreciation and Amortization (D&A)
8.64 8.54 8.56 8.01 8.03 7.74 8.38
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -5.63% -4.88% -2.93% -4.50% -4.58% -5.58%
Debt-free Net Working Capital to Revenue
0.00% 7.91% 11.89% 11.72% 8.79% 10.44% 6.06%
Net Working Capital to Revenue
0.00% 6.29% 10.96% 11.72% 8.79% 10.44% 6.06%
Earnings Adjustments
- - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $1.27 ($0.08) ($0.52) ($0.91) $0.17
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 81.26M 84.42M 91.54M 88.74M 88.22M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $1.27 ($0.08) ($0.52) ($0.91) $0.17
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 81.26M 84.42M 91.54M 88.74M 88.22M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 81.26M 84.42M 91.54M 88.74M 88.22M
Normalized Net Operating Profit after Tax (NOPAT)
-3.34 9.46 100 -3.18 -43 -47 40
Normalized NOPAT Margin
-0.43% 1.22% 7.39% -0.28% -4.55% -4.77% 3.83%
Pre Tax Income Margin
1.12% -5.99% 7.45% 0.01% -6.09% -7.62% 1.73%
Debt Service Ratios
- - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 -30.68 -2,303.46 -28.51 3.07
NOPAT to Interest Expense
0.00 0.00 0.00 1,887.85 -1,612.43 -16.39 6.58
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 -88.36 -2,522.86 -30.40 2.47
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 1,830.17 -1,831.82 -18.28 5.97
Payout Ratios
- - - - - - -
Dividend Payout Ratio
221.66% 0.00% 31.90% -253.95% -9.78% 0.00% 0.00%
Augmented Payout Ratio
221.66% 0.00% 31.90% -253.95% -9.78% 0.00% 0.00%

Quarterly Metrics And Ratios for Douglas Elliman

This table displays calculated financial ratios and metrics derived from Douglas Elliman's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
88,707,320.00 91,535,412.00 91,419,787.00 91,832,616.00 - 88,737,838.00 88,737,838.00 88,708,101.00 88,818,970.00 88,217,442.00 90,906,082.00
DEI Adjusted Shares Outstanding
88,707,320.00 91,535,412.00 91,419,787.00 91,832,616.00 - 88,737,838.00 88,737,838.00 88,708,101.00 88,818,970.00 88,217,442.00 90,906,082.00
DEI Earnings Per Adjusted Shares Outstanding
-0.17 -0.45 -0.02 -0.30 - -1.12 -0.26 -0.28 1.82 -0.95 -0.03
Growth Metrics
- - - - - - - - - - -
Revenue Growth
3.28% -6.42% 3.57% 5.87% 13.63% -100.00% -5.03% -1.31% 105.02% 0.00% 4.45%
EBITDA Growth
-8.51% -81.37% 72.34% -276.71% 33.58% 73.94% -1,062.96% 6.93% 973.62% -176.32% 92.92%
EBIT Growth
-7.82% -74.16% 55.73% -212.86% 31.03% 70.60% -512.61% 5.42% 802.72% -187.30% 84.78%
NOPAT Growth
-7.82% -74.16% 55.73% 15.76% 31.03% 74.20% -50.61% -43.39% 706.95% -227.37% 38.09%
Net Income Growth
19.52% -133.66% 65.62% -435.07% 59.46% 69.85% -1,171.07% 9.13% 1,322.82% -159.01% 87.92%
EPS Growth
21.74% -127.27% 66.67% -450.00% 66.67% 86.00% -1,250.00% 12.12% 1,433.33% -171.43% 88.89%
Operating Cash Flow Growth
86.76% 13.57% -84.37% 293.96% -239.70% 79.42% -51.29% -39.02% -60.26% -244.35% 1,704.51%
Free Cash Flow Firm Growth
51.95% 86.60% 166.59% 332.34% 315.48% 735.90% 203.87% -27.35% 12.40% -206.55% -146.85%
Invested Capital Growth
6.08% -20.93% -21.88% -62.52% -63.17% -57.81% -80.41% -130.88% 47.91% 55.32% 166.65%
Revenue Q/Q Growth
-14.87% -6.49% 42.71% -6.80% -8.63% -100.00% 0.00% -3.14% 89.79% -100.00% 0.00%
EBITDA Q/Q Growth
-216.27% -83.00% 95.58% -1,373.57% 44.24% -12.56% -97.10% -17.92% 433.93% -135.60% 94.95%
EBIT Q/Q Growth
-167.21% -75.91% 91.14% -651.35% 41.09% -10.12% -84.59% -15.99% 398.05% -145.02% 90.22%
NOPAT Q/Q Growth
-167.21% -75.91% 91.14% -102.31% -118.79% 34.20% 48.29% -92.61% 1,026.11% -135.49% 90.22%
Net Income Q/Q Growth
-192.75% -177.57% 95.73% -1,442.08% 77.82% -106.44% -80.02% -10.24% 398.47% -143.73% 91.60%
EPS Q/Q Growth
-200.00% -177.78% 96.00% -1,550.00% 81.82% -16.67% -285.71% -7.41% 375.86% -123.75% 84.21%
Operating Cash Flow Q/Q Growth
42.97% -932.97% 104.83% 581.79% -199.88% 37.42% 111.43% 753.58% -362.46% -34.48% 159.99%
Free Cash Flow Firm Q/Q Growth
12.88% 69.97% 419.84% 177.64% -19.20% -11.37% 52.84% -33.62% 25.01% -184.01% 32.80%
Invested Capital Q/Q Growth
-8.82% -8.01% -1.21% -54.77% -10.41% 5.40% -54.12% -171.29% 529.09% 10.68% -21.24%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
25.79% 13.27% 16.05% 15.91% 17.78% 0.00% 15.93% 17.70% 20.17% 0.00% 14.61%
EBITDA Margin
-10.08% -19.72% -0.61% -9.65% -5.89% 0.00% -7.47% -9.10% 16.01% 0.00% -0.51%
Operating Margin
-11.01% -20.71% -1.29% -2.79% -6.68% 0.00% -2.04% -4.05% 14.51% 0.00% -1.21%
EBIT Margin
-11.01% -20.71% -1.29% -10.36% -6.68% 0.00% -8.29% -9.93% 15.59% 0.00% -1.21%
Profit (Net Income) Margin
-7.01% -20.82% -0.62% -10.31% -2.50% 0.00% -8.34% -9.49% 14.92% 0.00% -0.96%
Tax Burden Percent
69.79% 102.95% 110.77% 100.00% 96.04% 100.00% 100.00% 100.04% 95.45% 100.00% 100.00%
Interest Burden Percent
91.29% 97.65% 43.75% 99.46% 38.99% 103.10% 100.55% 95.52% 100.26% 92.95% 79.82%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 4.55% 0.00% 0.00%
Return on Invested Capital (ROIC)
-82.09% -141.93% -8.95% -27.11% -73.71% 0.00% -22.21% -168.19% 339.35% 0.00% -29.33%
ROIC Less NNEP Spread (ROIC-NNEP)
-83.00% -131.99% -9.56% -11.36% -77.63% 0.00% -6.23% -154.87% 335.24% 0.00% -29.05%
Return on Net Nonoperating Assets (RNNOA)
53.49% 75.19% 5.49% 7.61% 52.90% 0.00% 4.36% 140.80% -253.49% 0.00% 23.30%
Return on Equity (ROE)
-28.60% -66.74% -3.46% -19.50% -20.82% 0.00% -17.84% -27.39% 85.86% 0.00% -6.03%
Cash Return on Invested Capital (CROIC)
-56.23% -36.41% -32.16% 14.40% 16.08% 37.20% 78.79% 0.00% 47.75% -10.97% -29.18%
Operating Return on Assets (OROA)
-20.15% -39.89% -2.49% -19.76% -13.48% 0.00% -13.59% -15.70% 34.34% 0.00% -2.71%
Return on Assets (ROA)
-12.84% -40.10% -1.21% -19.65% -5.05% 0.00% -13.67% -15.01% 32.86% 0.00% -2.16%
Return on Common Equity (ROCE)
-28.46% -66.44% -3.45% -19.44% -20.75% 0.00% -17.81% -27.39% 85.97% 0.00% -6.03%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-16 -29 -2.57 -5.20 -11 -7.49 -3.87 -7.46 69 -25 -2.40
NOPAT Margin
-7.71% -14.50% -0.90% -1.95% -4.68% 0.00% -1.43% -2.84% 13.85% 0.00% -0.85%
Net Nonoperating Expense Percent (NNEP)
0.91% -9.94% 0.61% -15.75% 3.92% -4.36% -15.98% -13.32% 4.11% -6.85% -0.28%
Return On Investment Capital (ROIC_SIMPLE)
-7.05% -14.82% -1.30% -2.52% -5.83% -3.91% -2.26% -4.99% 37.69% -14.59% -1.44%
Cost of Revenue to Revenue
74.21% 86.73% 83.95% 84.09% 82.22% 0.00% 84.07% 82.30% 79.83% 0.00% 85.39%
SG&A Expenses to Revenue
15.45% 13.49% 8.70% 10.76% 15.31% 0.00% 9.65% 12.26% -0.42% 0.00% 6.28%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
36.80% 33.98% 17.34% 18.71% 24.46% 0.00% 17.97% 21.76% -11.83% 0.00% 15.82%
Earnings before Interest and Taxes (EBIT)
-24 -41 -3.67 -28 -16 -12 -23 -26 78 -35 -3.43
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-22 -39 -1.74 -26 -14 -10 -20 -24 80 -28 -1.44
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.12 0.74 0.54 0.97 0.92 0.96 1.50 2.20 1.14 0.86 0.96
Price to Tangible Book Value (P/TBV)
2.04 1.61 1.15 2.44 2.58 2.83 6.17 23.01 2.63 2.25 2.54
Price to Revenue (P/Rev)
0.27 0.15 0.11 0.17 0.15 0.19 0.26 0.33 0.20 0.14 0.15
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 13.83 4.63 3.14
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 7.23% 21.62% 31.83%
Enterprise Value to Invested Capital (EV/IC)
1.31 0.41 0.00 0.85 0.61 0.84 5.15 0.00 1.53 0.58 0.86
Enterprise Value to Revenue (EV/Rev)
0.13 0.04 0.00 0.03 0.02 0.04 0.11 0.16 0.07 0.03 0.04
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.03 12.21 1.76
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.52 0.00 2.85
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.11 2.18 2.03
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 3.23 2.04 1.35 2.14 6.51 3.82 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.18 0.20 0.21 0.25 0.30 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.18 0.20 0.21 0.25 0.30 0.00 0.00 0.00
Financial Leverage
-0.64 -0.57 -0.57 -0.67 -0.68 -0.66 -0.70 -0.91 -0.76 -0.72 -0.80
Leverage Ratio
2.07 2.19 2.19 2.40 2.49 2.70 2.84 3.41 2.71 2.85 3.06
Compound Leverage Factor
1.89 2.14 0.96 2.39 0.97 2.78 2.86 3.25 2.72 2.65 2.45
Debt to Total Capital
0.00% 0.00% 0.00% 15.57% 16.75% 17.40% 19.81% 23.20% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 15.57% 16.75% 17.40% 19.81% 23.20% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.39% 0.36% 0.30% 0.16% 0.12% -0.03% -0.01% -0.18% -0.37% 0.00% 0.00%
Common Equity to Total Capital
99.61% 99.64% 99.70% 84.27% 83.13% 82.63% 80.20% 76.98% 100.37% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 -0.47 -0.43 -0.71 -0.52 -0.55 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 1.99 1.69 2.61 1.85 1.99 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 -0.47 -0.43 -0.71 -0.52 -0.55 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 -0.60 -0.68 -1.25 -1.22 -1.15 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 2.55 2.67 4.59 4.34 4.19 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 -0.60 -0.68 -1.25 -1.22 -1.15 0.00 0.00 0.00
Altman Z-Score
2.45 1.96 2.17 2.00 2.08 1.67 1.59 1.57 3.21 2.17 2.42
Noncontrolling Interest Sharing Ratio
0.49% 0.46% 0.43% 0.34% 0.29% 0.00% 0.17% 0.02% -0.13% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.86 1.67 1.78 2.29 2.13 1.95 1.99 1.92 1.63 1.48 1.53
Quick Ratio
1.46 1.20 1.32 1.93 1.79 1.57 1.62 1.60 1.37 1.14 1.21
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-22 -6.54 21 58 47 42 64 42 53 -44 -30
Operating Cash Flow to CapEx
-346.26% -1,311.44% 148.76% 688.06% -711.74% -543.23% 52.75% 693.67% -4,609.94% -7,467.95% 1,696.35%
Free Cash Flow to Firm to Interest Expense
0.00 -934.97 2,990.41 39.78 0.00 13.60 41.17 26.84 0.00 -7,390.57 -14,899.75
Operating Cash Flow to Interest Expense
0.00 -3,898.71 188.29 6.15 0.00 -1.84 0.42 3.48 0.00 -3,223.67 5,801.50
Operating Cash Flow Less CapEx to Interest Expense
0.00 -4,196.00 61.71 5.26 0.00 -2.17 -0.37 2.98 0.00 -3,266.83 5,459.50
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.83 1.93 1.94 1.91 2.02 1.67 1.64 1.58 2.20 2.22 2.24
Accounts Receivable Turnover
43.46 42.76 36.79 39.53 48.09 39.21 32.39 39.04 52.30 50.06 48.49
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
23.47 22.89 23.44 24.49 25.72 20.73 20.92 22.01 30.45 31.52 32.94
Accounts Payable Turnover
134.02 132.52 175.53 210.46 182.23 120.25 215.55 193.23 246.44 198.61 269.44
Days Sales Outstanding (DSO)
8.40 8.54 9.92 9.23 7.59 9.31 11.27 9.35 6.98 7.29 7.53
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
2.72 2.75 2.08 1.73 2.00 3.04 1.69 1.89 1.48 1.84 1.35
Cash Conversion Cycle (CCC)
5.67 5.78 7.84 7.50 5.59 6.27 9.58 7.46 5.50 5.45 6.17
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
92 85 84 38 34 36 16 -12 50 56 44
Invested Capital Turnover
10.65 9.79 9.95 13.88 15.76 13.17 15.56 59.27 24.51 22.58 34.67
Increase / (Decrease) in Invested Capital
5.29 -22 -24 -63 -58 -49 -67 -50 16 20 27
Enterprise Value (EV)
121 34 -6.94 32 21 30 85 127 77 32 38
Market Capitalization
262 145 106 168 149 153 206 254 211 145 161
Book Value per Share
$2.63 $2.13 $2.15 $1.89 $1.82 $1.78 $1.55 $1.30 $2.07 $1.91 $1.84
Tangible Book Value per Share
$1.44 $0.98 $1.01 $0.75 $0.65 $0.61 $0.38 $0.12 $0.90 $0.73 $0.70
Total Capital
234 196 198 206 195 191 172 149 183 168 167
Total Debt
0.00 0.00 0.00 32 33 33 34 35 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 32 33 33 34 35 0.00 0.00 0.00
Net Debt
-142 -111 -114 -136 -128 -122 -121 -127 -133 -112 -123
Capital Expenditures (CapEx)
0.76 2.08 0.89 1.31 1.26 1.03 1.22 0.79 0.31 0.26 0.68
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-43 -35 -30 -39 -46 -48 -47 -56 -58 -52 -56
Debt-free Net Working Capital (DFNWC)
84 62 71 116 104 95 96 92 63 49 55
Net Working Capital (NWC)
84 62 71 116 104 95 96 92 63 49 55
Net Nonoperating Expense (NNE)
-1.48 13 -0.79 22 -5.29 5.08 19 17 -5.37 8.04 0.34
Net Nonoperating Obligations (NNO)
-142 -111 -114 -136 -128 -122 -121 -127 -133 -112 -123
Total Depreciation and Amortization (D&A)
2.00 1.98 1.93 1.90 1.93 1.90 2.22 2.18 2.08 6.59 1.99
Debt-free, Cash-free Net Working Capital to Revenue
-4.50% -3.74% -3.13% -4.03% -4.58% -5.97% -5.97% -7.22% -5.58% -5.00% -5.36%
Debt-free Net Working Capital to Revenue
8.79% 6.61% 7.42% 11.99% 10.44% 11.99% 12.24% 11.87% 6.06% 4.72% 5.28%
Net Working Capital to Revenue
8.79% 6.61% 7.42% 11.99% 10.44% 11.99% 12.24% 11.87% 6.06% 4.72% 5.28%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.18) ($0.50) ($0.02) ($0.33) ($0.06) ($0.07) ($0.27) ($0.29) $0.80 ($0.19) ($0.03)
Adjusted Weighted Average Basic Shares Outstanding
91.54M 91.42M 91.83M 89.17M 88.74M 88.74M 88.71M 88.82M 88.22M 90.91M 90.89M
Adjusted Diluted Earnings per Share
($0.18) ($0.50) ($0.02) ($0.33) ($0.06) ($0.07) ($0.27) ($0.29) $0.80 ($0.19) ($0.03)
Adjusted Weighted Average Diluted Shares Outstanding
91.54M 91.42M 91.83M 89.17M 88.74M 88.74M 88.71M 88.82M 88.22M 90.91M 90.89M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
91.54M 91.42M 91.83M 89.17M 88.74M 88.74M 88.71M 88.82M 88.22M 90.91M 90.89M
Normalized Net Operating Profit after Tax (NOPAT)
-16 -17 -2.15 -5.19 -11 -7.49 -3.66 -5.31 70 -24 -2.30
Normalized NOPAT Margin
-7.56% -8.29% -0.75% -1.95% -4.55% 0.00% -1.35% -2.02% 13.95% 0.00% -0.81%
Pre Tax Income Margin
-10.05% -20.22% -0.56% -10.31% -2.61% 0.00% -8.34% -9.49% 15.63% 0.00% -0.96%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 -5,923.43 -524.71 -18.89 0.00 -3.98 -14.56 -16.59 0.00 -5,837.00 -1,712.50
NOPAT to Interest Expense
0.00 -4,146.40 -367.30 -3.56 0.00 -2.45 -2.51 -4.74 0.00 -4,085.90 -1,198.75
EBIT Less CapEx to Interest Expense
0.00 -6,220.71 -651.29 -19.78 0.00 -4.32 -15.35 -17.09 0.00 -5,880.17 -2,054.50
NOPAT Less CapEx to Interest Expense
0.00 -4,443.69 -493.87 -4.45 0.00 -2.79 -3.29 -5.24 0.00 -4,129.07 -1,540.75
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-9.78% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-9.78% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Douglas Elliman’s second-quarter 2026 results show meaningful sequential improvement, but the company remains unprofitable and exposed to a challenging real estate market. Revenue increased to $283.4 million from $271.4 million in the restated second quarter of 2025, a gain of approximately 4.5%. Gross profit declined to $41.4 million from $49.0 million, however, reducing the gross margin to approximately 14.6% from 18.1%.

The company’s operating loss narrowed substantially to $3.4 million in Q2 2026 from $5.5 million in Q2 2025 and $35.0 million in Q1 2026. Net loss attributable to common shareholders improved to $2.7 million, or $0.03 per share, compared with a $22.7 million loss, or $0.27 per share, in the year-ago quarter. The Q1 2026 income statement contains apparent reporting inconsistencies, including zero reported revenue and a net loss that does not reconcile with several other line items, so sequential comparisons should be treated cautiously.

Cash generation also improved. Operating cash flow was positive at $11.6 million in Q2 2026, compared with $642,000 in Q2 2025 and negative operating cash flow of $19.3 million in Q1 2026. Much of the latest quarter’s operating cash flow came from positive changes in operating assets and liabilities and noncash adjustments, rather than reported net income, which makes the improvement worth monitoring for sustainability.

  • Revenue growth resumed: Q2 2026 revenue rose approximately 4.5% year over year to $283.4 million, reversing the decline reported in Q2 2025.
  • Losses narrowed sharply: The operating loss fell to $3.4 million and the net loss attributable to common shareholders fell to $2.7 million, compared with losses of $5.5 million and $22.7 million, respectively, in Q2 2025.
  • Operating cash flow turned stronger: Douglas Elliman generated $11.6 million of operating cash flow in Q2 2026, helping cash and equivalents increase to $105.2 million from $95.7 million at the end of Q1.
  • Liquidity remains adequate in the near term: Cash and restricted cash totaled approximately $111.2 million at June 30, 2026, while current assets exceeded current liabilities by approximately $55.2 million, implying a current ratio of about 1.5.
  • Liabilities declined from the prior year: Total liabilities were $277.3 million at the end of Q2 2026, down from $351.4 million at June 30, 2025. The company also reported no long-term debt line item in the latest balance sheet, although changes in classification or presentation should be reviewed.
  • Cash flow remains volatile: Douglas Elliman generated positive operating cash flow in Q2 2026 but reported negative operating cash flow in Q1 2026 and Q4 2025. The latest improvement was supported by working-capital movements and noncash adjustments, which may not recur.
  • Balance-sheet presentation has changed: The latest filing does not separately report long-term debt, while earlier periods did. Investors should examine the filing notes to determine whether debt was repaid, reclassified, or included in another liability category.
  • Profitability remains unresolved: Despite improvement, the company still posted an operating loss and a net loss in Q2 2026. Retained earnings remained negative at approximately $127.7 million.
  • Gross-margin pressure continues: Gross profit fell year over year despite higher revenue, indicating that cost of revenue increased faster than sales and could limit the benefit of future revenue growth.
  • Cash reserves remain below recent levels: Cash and equivalents of $105.2 million were well below the $136.3 million reported at June 30, 2025 and the $151.4 million reported at September 30, 2024, leaving less cushion if operating losses return.

Overall, the latest quarter is encouraging because revenue, operating losses and operating cash flow all improved from the year-ago period. However, investors should look for several consecutive quarters of positive operating cash flow, stable gross margins and sustained profitability before concluding that Douglas Elliman’s turnaround is firmly established.

10/10/26 04:45 PM ETAI Generated. May Contain Errors.

Douglas Elliman Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Douglas Elliman's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Douglas Elliman's net income appears to be on a downward trend, with a most recent value of $14.31 million in 2025, rising from $8.46 million in 2019. The previous period was -$77.00 million in 2024. Find out what analysts predict for Douglas Elliman in the coming months.

Douglas Elliman's total operating income in 2025 was $45.48 million, based on the following breakdown:
  • Total Gross Profit: $190.36 million
  • Total Operating Expenses: $144.88 million

Over the last 6 years, Douglas Elliman's total revenue changed from $784.11 million in 2019 to $1.03 billion in 2025, a change of 31.7%.

In the past 11 quarters, Douglas Elliman's cash and equivalents has ranged from $91.45 million in Q1 2024 to $151.42 million in Q3 2024, and is currently $105.23 million as of their latest financial filing in Q2 2026.

Douglas Elliman had total debt of $0.00 at the end of 2025, a 100.0% decrease from 2024, and none in 2019.

Over the last 6 years, Douglas Elliman's book value per share changed from 0.00 in 2019 to 2.07 in 2025, a change of 207.1%.



Financial statements for NYSE:DOUG last updated on 8/10/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners